{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:52:42Z","timestamp":1780527162137,"version":"3.54.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP19dm0107119"],"award-info":[{"award-number":["JP19dm0107119"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["19K17054"],"award-info":[{"award-number":["19K17054"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The spleen is a large immune organ that plays a key role in the immune system. The precise molecular mechanisms underlying the relationship between the spleen and stress-related psychiatric disorders are unknown. Here we investigated the role of spleen in stress-related psychiatric disorders. FACS analysis was applied to determine the contribution of the spleen to susceptibility and resilience in mice that were subjected to chronic social defeat stress (CSDS). We found a notable increase in splenic volume and weight in CSDS-susceptible mice compared to control (no CSDS) mice and CSDS-resilient mice. The number of granulocytes, but not of T cells and B cells, in the spleen of susceptible mice was higher than in the spleen of both control and resilient mice. Interestingly, NKG2D (natural killer group 2, member D) expression in the spleen of CSDS-susceptible mice was higher than that in control mice and CSDS-resilient mice. In addition, NKG2D expression in the spleen of patients with depression was higher than that in controls. Both increased splenic weight and increased splenic NKG2D expression in CSDS-susceptible mice were ameliorated after a subsequent administration of (<jats:italic>R<\/jats:italic>)-ketamine. The present findings indicate a novel role of splenic NKG2D in stress susceptibility versus resilience in mice subjected to CSDS. Furthermore, abnormalities in splenic functions in CSDS-susceptible mice were ameliorated after subsequent injection of (<jats:italic>R<\/jats:italic>)-ketamine. Thus, the brain\u2013spleen axis might, at least in part, contribute to the pathogenesis of stress-related psychiatric disorders such as depression.<\/jats:p>","DOI":"10.1007\/s00406-019-01092-z","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T16:02:41Z","timestamp":1577203361000},"page":"447-456","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":59,"title":["Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine"],"prefix":"10.1007","volume":"271","author":[{"given":"Kai","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akemi","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8892-0439","authenticated-orcid":false,"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"1092_CR1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1998.tb09546.x","volume":"840","author":"BS McEwen","year":"1998","unstructured":"McEwen BS (1998) Stress, adaptation, and disease. Allostasis and allostatic load. Ann N Y Acad Sci 840:33\u201344","journal-title":"Ann N Y Acad Sci"},{"key":"1092_CR2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1146\/annurev.clinpsy.1.102803.143948","volume":"1","author":"SM Southwick","year":"2005","unstructured":"Southwick SM, Vythilingam M, Charney DS (2005) The psychobiology of depression and resilience to stress: implications for prevention and treatment. Ann Rev Clin Psychol 1:255\u2013291","journal-title":"Ann Rev Clin Psychol"},{"key":"1092_CR3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nrn2649","volume":"10","author":"A Feder","year":"2009","unstructured":"Feder A, Nestler EJ, Charney DS (2009) Psychobiology and molecular genetics of resilience. Nat Rev Neurosci 10:446\u2013457","journal-title":"Nat Rev Neurosci"},{"key":"1092_CR4","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.neuron.2012.08.016","volume":"75","author":"TB Franklin","year":"2012","unstructured":"Franklin TB, Saab BJ, Mansuy IM (2012) Neural mechanisms of stress resilience and vulnerability. Neuron 75:747\u2013761","journal-title":"Neuron"},{"key":"1092_CR5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/nn.3234","volume":"15","author":"SJ Russo","year":"2012","unstructured":"Russo SJ, Murrough JW, Han MH, Charney DS, Nestler EJ (2012) Neurobiology of resilience. Nat Neurosci 15:1475\u20131484","journal-title":"Nat Neurosci"},{"key":"1092_CR6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bbi.2018.08.010","volume":"74","author":"R Dantzer","year":"2018","unstructured":"Dantzer R, Cohen S, Russo SJ, Dinan TG (2018) Resilience and immunity. Brain Behav Immun 74:28\u201342","journal-title":"Brain Behav Immun"},{"key":"1092_CR7","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.biopsych.2019.04.011","volume":"86","author":"F Cathomas","year":"2019","unstructured":"Cathomas F, Murrough JW, Nestler EJ, Han MH, Russo SJ (2019) Neurobiology of resilience: interface between mind and body. Biol Psychiatry 86:410\u2013420","journal-title":"Biol Psychiatry"},{"key":"1092_CR8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1037\/0033-2909.130.4.601","volume":"130","author":"SC Segerstrom","year":"2004","unstructured":"Segerstrom SC, Miller GE (2004) Psychological stress and human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull 130:601\u2013630","journal-title":"Psychol Bull"},{"key":"1092_CR9","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/nrendo.2009.106","volume":"5","author":"GP Chrousos","year":"2009","unstructured":"Chrousos GP (2009) Stress and disorders of the stress system. Nat Rev Endocrinol 5:374\u2013381","journal-title":"Nat Rev Endocrinol"},{"key":"1092_CR10","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/npp.2016.90","volume":"42","author":"C M\u00e9nard","year":"2016","unstructured":"M\u00e9nard C, Pfau ML, Hodes GE, Russo SJ (2016) Immune system and neuroendocrine mechanisms of stress vulnerability and resilience. Neuropsychopharmacology 42:62\u201380","journal-title":"Neuropsychopharmacology"},{"key":"1092_CR11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ynstr.2014.09.004","volume":"1","author":"ML Pfau","year":"2015","unstructured":"Pfau ML, Russo SJ (2015) Peripheral and central mechanisms of stress resilience. Neurobiol Stress. 1:66\u201379","journal-title":"Neurobiol Stress."},{"key":"1092_CR12","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nri1669","volume":"5","author":"RE Mebius","year":"2005","unstructured":"Mebius RE, Kraal G (2005) Structure and function of the spleen. Nat Rev Immunol 5:606\u2013616","journal-title":"Nat Rev Immunol"},{"key":"1092_CR13","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.immuni.2013.10.010","volume":"39","author":"V Bronte","year":"2013","unstructured":"Bronte V, Pittet MJ (2013) The spleen in local and systemic regulation of immunity. Immunity 39:806\u2013818","journal-title":"Immunity"},{"key":"1092_CR14","doi-asserted-by":"crossref","unstructured":"Lewis SM, Williams A, Eisenbarth SC (2019) Structure and function of the immune system in the spleen. Sci Immunol 4:eaau6085","DOI":"10.1126\/sciimmunol.aau6085"},{"key":"1092_CR15","doi-asserted-by":"crossref","first-page":"R1180","DOI":"10.1152\/ajpregu.00307.2007","volume":"293","author":"MT Bailey","year":"2007","unstructured":"Bailey MT, Engler H, Powell ND, Padgett DA, Sheridan JF (2007) Repeated social defeat increases the bactericidal activity of splenic macrophages through a Toll-like receptor-dependent pathway. Am J Physiol Regul Integr Comp Physiol 293:R1180\u2013R1190","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1092_CR16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbi.2008.09.010","volume":"23","author":"ND Powell","year":"2009","unstructured":"Powell ND, Bailey MT, Mays JW et al (2009) Repeated social defeat activates dendritic cells and enhances Toll-like receptor dependent cytokine secretion. Brain Behav Immun 23:225\u2013231","journal-title":"Brain Behav Immun"},{"key":"1092_CR17","doi-asserted-by":"crossref","first-page":"6501","DOI":"10.1038\/s41598-017-06956-9","volume":"7","author":"W Jiang","year":"2017","unstructured":"Jiang W, Li Y, Sun J et al (2017) Spleen contributes to restraint stress induced changes in blood leukocytes distribution. Sci Rep 7:6501","journal-title":"Sci Rep"},{"key":"1092_CR18","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.it.2008.04.007","volume":"29","author":"S Gonz\u00e1lez","year":"2008","unstructured":"Gonz\u00e1lez S, L\u00f3pez-Soto A, Suarez-Alvarez B, L\u00f3pez-Vazquez A, L\u00f3pez-Larrea C (2008) NKG2D ligands: key targets of the immune response. Trends Immunol 29:397\u2013403","journal-title":"Trends Immunol"},{"key":"1092_CR19","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","volume":"31","author":"DH Raulet","year":"2013","unstructured":"Raulet DH, Gasser S, Gowen BG, Deng W, Jung H (2013) Regulation of ligands for the NKG2D activating receptor. Annu Rev Immunol 31:413\u2013441","journal-title":"Annu Rev Immunol"},{"key":"1092_CR20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3389\/fimmu.2018.00476","volume":"9","author":"A Zingoni","year":"2018","unstructured":"Zingoni A, Molfetta R, Fionda C et al (2018) NKG2D and its ligands: \u201cOne for all, all for one\u201d. Front Immunol 9:476","journal-title":"Front Immunol"},{"key":"1092_CR21","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fimmu.2018.01219","volume":"9","author":"M Babic","year":"2018","unstructured":"Babic M, Romagnani C (2018) The role of natural killer group 2, member D in chronic inflammation and autoimmunity. Front Immunol 9:1219","journal-title":"Front Immunol"},{"key":"1092_CR22","doi-asserted-by":"crossref","first-page":"659","DOI":"10.12688\/f1000research.14344.1","volume":"7","author":"RS Duman","year":"2018","unstructured":"Duman RS (2018) Ketamine and rapid-acting antidepressants: a new era in the battle against depression and suicide. F1000Res 7:659","journal-title":"F1000Res"},{"key":"1092_CR23","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","volume":"70","author":"P Zanos","year":"2018","unstructured":"Zanos P, Moaddel R, Morris PJ et al (2018) Ketamine and ketamine metabolites pharmacology: insights into therapeutic mechanisms. Pharmacol Rev 70:621\u2013660","journal-title":"Pharmacol Rev"},{"key":"1092_CR24","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuron.2019.02.005","volume":"101","author":"JH Krystal","year":"2019","unstructured":"Krystal JH, Abdallah CG, Sanacora G, Charney D, Duman RS (2019) Ketamine: a paradigm shift for depression research and treatment. Neuron 101:774\u2013778","journal-title":"Neuron"},{"key":"1092_CR25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","volume":"19","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hashimoto K (2019) An update on ketamine and its two enantiomers as rapid-acting antidepressants. Expert Rev Neurother 19:83\u201392","journal-title":"Expert Rev Neurother"},{"key":"1092_CR26","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","volume":"73","author":"K Hashimoto","year":"2019","unstructured":"Hashimoto K (2019) Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective. Psychiatry Clin Neurosci 73:613\u2013627","journal-title":"Psychiatry Clin Neurosci"},{"key":"1092_CR27","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","volume":"9","author":"C Yang","year":"2019","unstructured":"Yang C, Yang J, Luo A, Hashimoto K (2019) Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites. Transl Psychiatry 9:280","journal-title":"Transl Psychiatry"},{"key":"1092_CR28","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","volume":"116","author":"JC Zhang","year":"2014","unstructured":"Zhang JC, Li SX, Hashimoto K (2014) R(-)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine. Pharmacol Biochem Behav 116:137\u2013141","journal-title":"Pharmacol Biochem Behav"},{"key":"1092_CR29","doi-asserted-by":"crossref","unstructured":"Yang C, Shirayama Y, Zhang JC, et al. (2015) R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects. Transl Psychiatry 5:e632","DOI":"10.1038\/tp.2015.136"},{"key":"1092_CR30","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1017\/S0033291716000969","volume":"46","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto K (2016) R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity. Psychol Med 46:2449\u20132451","journal-title":"Psychol Med"},{"key":"1092_CR31","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","volume":"20","author":"K Hashimoto","year":"2016","unstructured":"Hashimoto K (2016) Ketamine\u2019s antidepressant action: beyond NMDA receptor inhibition. Expert Opin Ther Targets 20:1389\u20131392","journal-title":"Expert Opin Ther Targets"},{"key":"1092_CR32","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.biopsych.2016.12.020","volume":"82","author":"C Yang","year":"2017","unstructured":"Yang C, Qu Y, Abe M, Nozawa D, Chaki S, Hashimoto K (2017) (R)-Ketamine shows greater potency and longer lasting antidepressant effects than its metabolite (2R,6R)-hydroxynorketamine. Biol Psychiatry 82:e43\u2013e44","journal-title":"Biol Psychiatry"},{"key":"1092_CR33","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","volume":"7","author":"C Yang","year":"2017","unstructured":"Yang C, Qu Y, Fujita Y et al (2017) Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. Transl Psychiatry 7:1294","journal-title":"Transl Psychiatry"},{"key":"1092_CR34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","volume":"83","author":"C Yang","year":"2018","unstructured":"Yang C, Ren Q, Qu Y et al (2018) Mechanistic target of rapamycin-independent antidepressant effects of (R)-ketamine in a social defeat stress model. Biol Psychiatry 83:18\u201328","journal-title":"Biol Psychiatry"},{"key":"1092_CR35","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","volume":"181","author":"L Chang","year":"2019","unstructured":"Chang L, Zhang K, Pu Y et al (2019) Comparison of antidepressant and side effects in mice after intranasal administration of (R, S)-ketamine, (R)-ketamine, and (S)-ketamine. Pharmacol Biochem Behav 181:53\u201359","journal-title":"Pharmacol Biochem Behav"},{"key":"1092_CR36","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/nprot.2011.361","volume":"6","author":"SA Golden","year":"2011","unstructured":"Golden SA, Covington HER 3rd, Berton O, Russo SJ (2011) A standardized protocol for repeated social defeat stress in mice. Nat Protocol 6:1183\u20131191","journal-title":"Nat Protocol"},{"key":"1092_CR37","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.biopsych.2018.11.006","volume":"85","author":"K Zhang","year":"2019","unstructured":"Zhang K, Hashimoto K (2019) Lack of opioid system in the antidepressant actions of ketamine. Biol Psychiatry 85:e25\u2013e27","journal-title":"Biol Psychiatry"},{"key":"1092_CR38","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.1007\/s00213-015-4062-3","volume":"232","author":"JC Zhang","year":"2015","unstructured":"Zhang JC, Yao W, Dong C et al (2015) Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression. Psychopharmacology 232:4325\u20134335","journal-title":"Psychopharmacology"},{"key":"1092_CR39","first-page":"228","volume":"20","author":"C Dong","year":"2017","unstructured":"Dong C, Zhang JC, Yao W et al (2017) Rapid and sustained antidepressant action of the mGlu2\/3 receptor antagonist MGS0039 in the social defeat stress model: comparison with ketamine. Int J Neuropsychopharmacol 20:228\u2013236","journal-title":"Int J Neuropsychopharmacol"},{"key":"1092_CR40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-9964(99)00192-9","volume":"44","author":"EF Torrey","year":"2000","unstructured":"Torrey EF, Webster M, Knable M, Johnston N, Yolken RH (2000) The Stanley foundation brain collection and neuropathology consortium. Schizophrenia Res 44:151\u2013155","journal-title":"Schizophrenia Res"},{"key":"1092_CR41","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.biopsych.2007.03.017","volume":"62","author":"K Hashimoto","year":"2007","unstructured":"Hashimoto K, Sawa A, Iyo M (2007) Increased levels of glutamate in brains from patients with mood disorders. Biol Psychiatry 62:1310\u20131316","journal-title":"Biol Psychiatry"},{"key":"1092_CR42","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1038\/tp.2017.95","volume":"7","author":"B Yang","year":"2017","unstructured":"Yang B, Ren Q, Zhang JC, Chen QX, Hashimoto K (2017) Altered expression of BDNF, BDNF pro-peptide and their precursor proBDNF in brain and liver tissues from psychiatric disorders: rethinking the brain-liver axis. Transl Psychiatry 7:e1128","journal-title":"Transl Psychiatry"},{"key":"1092_CR43","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jad.2018.11.016","volume":"245","author":"Z Xiong","year":"2019","unstructured":"Xiong Z, Zhang K, Ren Q, Chang L, Chen J, Hashimoto K (2019) Increased expression of inwardly rectifying Kir4.1 channel in the parietal cortex from patients with major depressive disorder. J Affect Disord 245:265\u2013269","journal-title":"J Affect Disord"},{"key":"1092_CR44","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.imlet.2017.04.006","volume":"189","author":"V Jelen\u010di\u0107","year":"2017","unstructured":"Jelen\u010di\u0107 V, Lenarti\u0107 M, Wensveen FM, Poli\u0107 B (2017) NKG2D: a versatile player in the immune system. Immunol Lett 189:48\u201353","journal-title":"Immunol Lett"},{"key":"1092_CR45","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1016\/j.celrep.2018.10.102","volume":"25","author":"DB McKim","year":"2018","unstructured":"McKim DB, Yin W, Wang Y, Cole SW, Godbout JP, Sheridan JF (2018) Social stress mobilizes hematopoietic stem cells to establish persistent splenic myelopoiesis. Cell Rep 25:2552\u20132562","journal-title":"Cell Rep"},{"key":"1092_CR46","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/14728222.2019.1580693","volume":"23","author":"M Lazarova","year":"2019","unstructured":"Lazarova M, Steine A (2019) The NKG2D axis: an emerging target in cancer immunotherapy. Expert Opin Ther Targets 23:281\u2013294","journal-title":"Expert Opin Ther Targets"},{"key":"1092_CR47","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.immuni.2009.06.017","volume":"31","author":"B Zafirova","year":"2009","unstructured":"Zafirova B, Mandari\u0107 S, Antulov R et al (2009) Altered NK cell development and enhanced NK cell-mediated resistance to mouse cytomegalovirus in NKG2D-deficient mice. Immunity 31:270\u2013282","journal-title":"Immunity"},{"key":"1092_CR48","doi-asserted-by":"crossref","first-page":"E1997","DOI":"10.3390\/ijms18091997","volume":"8","author":"K Vadstrup","year":"2017","unstructured":"Vadstrup K, Bendtsen F (2017) Anti-NKG2D mAb: a new treatment for Crohn's disease? Int J Mol Sci 8:E1997","journal-title":"Int J Mol Sci"},{"key":"1092_CR49","doi-asserted-by":"crossref","first-page":"45942","DOI":"10.1038\/srep45942","volume":"7","author":"C Yang","year":"2017","unstructured":"Yang C, Fujita Y, Ren Q, Ma M, Dong C, Hashimoto K (2017) Bifidobacterium in the gut microbiota confer resilience to chronic social defeat stress in mice. Sci Rep 7:45942","journal-title":"Sci Rep"},{"key":"1092_CR50","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.bbi.2017.06.009","volume":"66","author":"JK Szyszkowicz","year":"2017","unstructured":"Szyszkowicz JK, Wong A, Anisman H, Merali Z, Audet MC (2017) Implications of the gut microbiota in vulnerability to the social avoidance effects of chronic social defeat in male mice. Brain Behav Immun 66:45\u201355","journal-title":"Brain Behav Immun"},{"key":"1092_CR51","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/dev.21775","volume":"61","author":"AC Kentner","year":"2019","unstructured":"Kentner AC, Cryan JF, Brummelte S (2019) Resilience priming: Translational models for understanding resiliency and adaptation to early life adversity. Dev Psychobiol 61:350\u2013375","journal-title":"Dev Psychobiol"},{"key":"1092_CR52","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.bbi.2019.05.004","volume":"80","author":"A Gururajan","year":"2019","unstructured":"Gururajan A, van de Wouw M, Boehme M et al (2019) Resilience to chronic stress is associated with specific neurobiological, neuroendocrine and immune responses. Brain Behav Immun 80:583\u2013594","journal-title":"Brain Behav Immun"},{"key":"1092_CR53","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41398-019-0571-x","volume":"9","author":"K Zhang","year":"2019","unstructured":"Zhang K, Fujita Y, Chang L et al (2019) Abnormal composition of gut microbiota is associated with resilience versus susceptibility to inescapable electric stress. Transl Psychiatry 9:231","journal-title":"Transl Psychiatry"},{"key":"1092_CR54","doi-asserted-by":"crossref","unstructured":"Wang S, Qu Y, Chang L, Pu Y, Zhang K, Hashimoto K (2020) Antibiotic-induced microbiome depletion is associated with resilience in mice after chronic social defeat stress. J Affect Disord 260:448\u2013457","DOI":"10.1016\/j.jad.2019.09.064"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01092-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-019-01092-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-019-01092-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,20]],"date-time":"2021-03-20T12:05:34Z","timestamp":1616241934000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-019-01092-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["1092"],"URL":"https:\/\/doi.org\/10.1007\/s00406-019-01092-z","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,24]]},"assertion":[{"value":"8 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Hashimoto is an inventor on the filed patent on \u201cThe use of (<i>R<\/i>)-ketamine in the treatment of psychiatric diseases\u201d. Other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}